The Multifaceted Interplay between Atrial Fibrillation and Myocardial Infarction: A Review
This review was conducted to emphasize the complex interplay between atrial fibrillation (AF) and myocardial infraction (MI). In type 1 (T1) MI, AF is frequent and associated with excess mortality. Moreover, AF after hospital discharge for T1MI is not rare, suggesting the need to improve AF screenin...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/2/198 |
_version_ | 1797415067534229504 |
---|---|
author | Alban Belkouche Hermann Yao Alain Putot Frédéric Chagué Luc Rochette Nicolas Danchin Laurent Fauchier Marianne Zeller Yves Cottin |
author_facet | Alban Belkouche Hermann Yao Alain Putot Frédéric Chagué Luc Rochette Nicolas Danchin Laurent Fauchier Marianne Zeller Yves Cottin |
author_sort | Alban Belkouche |
collection | DOAJ |
description | This review was conducted to emphasize the complex interplay between atrial fibrillation (AF) and myocardial infraction (MI). In type 1 (T1) MI, AF is frequent and associated with excess mortality. Moreover, AF after hospital discharge for T1MI is not rare, suggesting the need to improve AF screening and to develop therapeutic strategies for AF recurrence. Additionally, AF is a common trigger for type 2 MI (T2MI), and recent data have shown that tachyarrhythmia or bradyarrhythmia could be a causal factor in, respectively, 13–47% or 2–7% of T2MI. In addition, AF is involved in T2MI pathogenesis as a result of severe anemia related to anticoagulants. AF is also an underestimated and frequent cause of coronary artery embolism (CE), as a situation at risk of myocardial infarction with non-obstructive coronary arteries. AF-causing CE is difficult to diagnose and requires specific management. Moreover, patients with both AF and chronic coronary syndromes represent a therapeutic challenge because the treatment of AF include anticoagulation, depending on the embolic risk, and ischemic heart disease management paradoxically includes antiplatelet therapy. |
first_indexed | 2024-03-09T05:42:42Z |
format | Article |
id | doaj.art-f40ca0be2aa043cf98d9d01a6a06b456 |
institution | Directory Open Access Journal |
issn | 2077-0383 |
language | English |
last_indexed | 2024-03-09T05:42:42Z |
publishDate | 2021-01-01 |
publisher | MDPI AG |
record_format | Article |
series | Journal of Clinical Medicine |
spelling | doaj.art-f40ca0be2aa043cf98d9d01a6a06b4562023-12-03T12:24:08ZengMDPI AGJournal of Clinical Medicine2077-03832021-01-0110219810.3390/jcm10020198The Multifaceted Interplay between Atrial Fibrillation and Myocardial Infarction: A ReviewAlban Belkouche0Hermann Yao1Alain Putot2Frédéric Chagué3Luc Rochette4Nicolas Danchin5Laurent Fauchier6Marianne Zeller7Yves Cottin8Department of Cardiology, University Teaching Hospital of Dijon Bourgogne, 21000 Dijon, FranceDepartment of Cardiology, University Teaching Hospital of Dijon Bourgogne, 21000 Dijon, FranceDepartment of Geriatry, University Teaching Hospital Dijon Bourgogne, 21000 Dijon, FranceDepartment of Cardiology, University Teaching Hospital of Dijon Bourgogne, 21000 Dijon, FranceTeam PEC2, EA 7460, University of Burgundy, 21078 Dijon, FranceDepartment of Cardiology, University Teaching Hospital of Georges Pompidou, 75015 Paris, FranceDepartment of Cardiology, University Teaching Hospital of Trousseau and University François Rabelais, 37000 Tours, FranceTeam PEC2, EA 7460, University of Burgundy, 21078 Dijon, FranceDepartment of Cardiology, University Teaching Hospital of Dijon Bourgogne, 21000 Dijon, FranceThis review was conducted to emphasize the complex interplay between atrial fibrillation (AF) and myocardial infraction (MI). In type 1 (T1) MI, AF is frequent and associated with excess mortality. Moreover, AF after hospital discharge for T1MI is not rare, suggesting the need to improve AF screening and to develop therapeutic strategies for AF recurrence. Additionally, AF is a common trigger for type 2 MI (T2MI), and recent data have shown that tachyarrhythmia or bradyarrhythmia could be a causal factor in, respectively, 13–47% or 2–7% of T2MI. In addition, AF is involved in T2MI pathogenesis as a result of severe anemia related to anticoagulants. AF is also an underestimated and frequent cause of coronary artery embolism (CE), as a situation at risk of myocardial infarction with non-obstructive coronary arteries. AF-causing CE is difficult to diagnose and requires specific management. Moreover, patients with both AF and chronic coronary syndromes represent a therapeutic challenge because the treatment of AF include anticoagulation, depending on the embolic risk, and ischemic heart disease management paradoxically includes antiplatelet therapy.https://www.mdpi.com/2077-0383/10/2/198atrial fibrillationchronic coronary syndromebleedingtype 1 and type 2 myocardial infarction |
spellingShingle | Alban Belkouche Hermann Yao Alain Putot Frédéric Chagué Luc Rochette Nicolas Danchin Laurent Fauchier Marianne Zeller Yves Cottin The Multifaceted Interplay between Atrial Fibrillation and Myocardial Infarction: A Review Journal of Clinical Medicine atrial fibrillation chronic coronary syndrome bleeding type 1 and type 2 myocardial infarction |
title | The Multifaceted Interplay between Atrial Fibrillation and Myocardial Infarction: A Review |
title_full | The Multifaceted Interplay between Atrial Fibrillation and Myocardial Infarction: A Review |
title_fullStr | The Multifaceted Interplay between Atrial Fibrillation and Myocardial Infarction: A Review |
title_full_unstemmed | The Multifaceted Interplay between Atrial Fibrillation and Myocardial Infarction: A Review |
title_short | The Multifaceted Interplay between Atrial Fibrillation and Myocardial Infarction: A Review |
title_sort | multifaceted interplay between atrial fibrillation and myocardial infarction a review |
topic | atrial fibrillation chronic coronary syndrome bleeding type 1 and type 2 myocardial infarction |
url | https://www.mdpi.com/2077-0383/10/2/198 |
work_keys_str_mv | AT albanbelkouche themultifacetedinterplaybetweenatrialfibrillationandmyocardialinfarctionareview AT hermannyao themultifacetedinterplaybetweenatrialfibrillationandmyocardialinfarctionareview AT alainputot themultifacetedinterplaybetweenatrialfibrillationandmyocardialinfarctionareview AT fredericchague themultifacetedinterplaybetweenatrialfibrillationandmyocardialinfarctionareview AT lucrochette themultifacetedinterplaybetweenatrialfibrillationandmyocardialinfarctionareview AT nicolasdanchin themultifacetedinterplaybetweenatrialfibrillationandmyocardialinfarctionareview AT laurentfauchier themultifacetedinterplaybetweenatrialfibrillationandmyocardialinfarctionareview AT mariannezeller themultifacetedinterplaybetweenatrialfibrillationandmyocardialinfarctionareview AT yvescottin themultifacetedinterplaybetweenatrialfibrillationandmyocardialinfarctionareview AT albanbelkouche multifacetedinterplaybetweenatrialfibrillationandmyocardialinfarctionareview AT hermannyao multifacetedinterplaybetweenatrialfibrillationandmyocardialinfarctionareview AT alainputot multifacetedinterplaybetweenatrialfibrillationandmyocardialinfarctionareview AT fredericchague multifacetedinterplaybetweenatrialfibrillationandmyocardialinfarctionareview AT lucrochette multifacetedinterplaybetweenatrialfibrillationandmyocardialinfarctionareview AT nicolasdanchin multifacetedinterplaybetweenatrialfibrillationandmyocardialinfarctionareview AT laurentfauchier multifacetedinterplaybetweenatrialfibrillationandmyocardialinfarctionareview AT mariannezeller multifacetedinterplaybetweenatrialfibrillationandmyocardialinfarctionareview AT yvescottin multifacetedinterplaybetweenatrialfibrillationandmyocardialinfarctionareview |